Drug Approval | July 24, 2022
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Mittal will be driving expansion of the provider network across India
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Lacosamide Injection is used to treat partial-onset seizures.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Already an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price
Subscribe To Our Newsletter & Stay Updated
